Directeur, Accès au Marché, Pricing

The Role Genmab is preparing to launch a new innovation in cervical cancer in Europe. In this role, you will lead development of the French Market Access strategy for the company’s oncology pipeline. Specifically, the Market access strategy, pricing and public affairs director will lead efforts in assessing and communicating to internal and external stakeholders the market access requirements of France for oncology, contributing to and shaping the overall value strategy for our brands throughout lifecycle. The position will drive development of local market access strategy, delivery of HTA submissions, and lead P&R negotiations. In this role, the director will also develop and implement a strong public affairs plan in collaboration with the GM. Responsibilities Identify, analyze, develop, and implement recommendations and strategies regarding P&R policy and challenges important to the company’s product portfolio. Analyze, synthesize, and translate technical P&R information, including coverage and reimbursement policies, into meaningful decision points, recommendations, and strategic tactics. Champion the P&R requirements for French Commercial Operations throughout commercialization and ensure alignment between all stakeholders internally as to prioritized needs. Contribute to strategy discussions and communication efforts with relevant external stakeholders including key government agencies and organizations. Partner in development of European and global value access & pricing deliverables, working in close collaboration with European and global colleagues and external vendors as needed. Drive development of French market access deliverables including HTA submissions; local evidence generation plans; negotiation strategies, and country-level regional and local market access tactics to secure reimbursement. Develop HTA payer and advocacy engagement plans and other external experts. Maintain alignment of local market access strategy to European and Global Market Access Strategy; establish pricing position within EU PriceBand. Collaborate closely with relevant internal stakeholders, including Marketing, Medical Affairs, Regulatory, etc. Requirements 10 to 15 years of experience within the field of Market Access & pricing. Experience in Health Economics and Outcomes Research is a plus. Strong network of relevant stakeholders in France. Strong knowledge of the market access & pricing landscape. Strong oncology market knowledge from a commercial and clinical studies perspective. Excellent communication and negotiation skills. Business fluency in English. Fluency in local language is a must. In order to be considered please apply with an English resume. About You Genuinely passionate about our purpose. Bring precision and excellence to all that you do. Believe in our rooted‑in‑science approach to problem‑solving. Generous collaborator who can work in teams with a broad spectrum of backgrounds. Take pride in enabling the best work of others on the team. Can grapple with the unknown and be innovative. Have experience working in a fast‑growing, dynamic company (or a strong desire to). Work hard and are not afraid to have a little fun while doing so Locations Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work‑life balance. Our offices are crafted as open, community‑based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard‑working, innovative and collaborative team has invented next‑generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T‑cell engagers, antibody‑drug conjugates, next‑generation immune checkpoint modulators and effector‑function‑enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock‑Your‑Socks‑Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X. Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com). Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed‑term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract. #J-18808-Ljbffr